Products - Digital health | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 83 products

Date | Title

Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTE25)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
7 May 2025
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment (HTE24)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
1 May 2025
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
10 February 2025
Published:
28 September 2023
Digital technologies to support self-management of COPD: early value assessment (HTE19)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
4 February 2025
Published:
19 December 2024
Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessment (HTE20)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
14 January 2025
Digitally enabled therapies for adults with depression: early value assessment (HTE8)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
14 January 2025
Published:
16 May 2023
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
24 October 2024
Artificial intelligence (AI)-derived software to help clinical decision making in stroke (DG57)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
2 May 2024
Published:
23 January 2024
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
30 April 2024
GaitSmart rehabilitation exercise programme for gait and mobility issues (MTG78)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
3 April 2024
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
25 March 2024
ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
14 March 2024
Published:
28 March 2023
Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
6 March 2024
Published:
26 October 2023
Digital technologies for managing non-specific low back pain: early value assessment (HTE16)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
5 March 2024
Devices for remote monitoring of Parkinson’s disease (DG51)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
25 January 2024
Published:
25 January 2023
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
14 December 2023
Published:
16 May 2023
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
15 November 2023
Virtual ward platform technologies for acute respiratory infections: early value assessment (HTE13)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
12 October 2023
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
27 September 2023
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment (HTE10)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
26 September 2023
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
5 September 2023
Published:
8 February 2023
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
10 August 2023
Published:
30 March 2023
KardiaMobile for detecting atrial fibrillation (MTG64)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
25 July 2023
Published:
6 January 2022
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images (DG55)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
5 July 2023
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
7 June 2023
MRI fusion biopsy systems for diagnosing prostate cancer (DG53)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
24 May 2023
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (DG52)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
24 May 2023
AposHealth for knee osteoarthritis (MTG76)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
11 April 2023
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
9 March 2023
MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
12 January 2023
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
5 October 2022
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
27 July 2022
Thopaz+ portable digital system for managing chest drains (MTG37)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
6 June 2022
Published:
21 March 2018
Sleepio to treat insomnia and insomnia symptoms (MTG70)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
20 May 2022
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
19 May 2021
Published:
13 February 2017
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
17 March 2021
Zio XT for detecting cardiac arrhythmias (MTG52)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
1 December 2020
Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
28 October 2020
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
2 September 2020
High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
26 August 2020
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) (DG39)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
17 June 2020
SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
19 February 2020
Published:
10 February 2016
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
17 January 2020
Published:
23 September 2015
gammaCore for cluster headache (MTG46)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
3 December 2019
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
13 November 2019
Rapid tests for group A streptococcal infections in people with a sore throat (DG38)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
13 November 2019
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
10 July 2019
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (DG35)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
8 May 2019
Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
4 July 2018
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
25 April 2018
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
19 December 2017
Published:
24 September 2014
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
15 November 2017
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
6 July 2017
Published:
25 January 2012
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
21 June 2017
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
10 May 2017
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
22 February 2017
High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
9 November 2016
ImmunoCAP ISAC 112 for multiplex allergen testing (DG24)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
18 May 2016
Therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) (DG22)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
17 February 2016
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions (DG19)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
11 November 2015
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (DG18)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
7 October 2015
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
10 December 2014
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (DG13)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
20 August 2014
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer (DG9)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
14 August 2013
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer (DG8)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
7 August 2013
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
21 November 2012
The EOS 2D/3D imaging system (DG1)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
26 October 2011
Computed tomographic colonography (virtual colonoscopy) (IPG129)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 June 2005
Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) (QS210)
Product type:
Quality standard
Published:
31 October 2023
Digital front door technologies to gather information for assessments for NHS Talking Therapies for anxiety and depression: Early Value Assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
24 July 2025
Digital self-help for people with eating disorders: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
13 November 2025
Digital platforms to support cardiac rehabilitation: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
18 November 2025
Digital technologies for managing mild to moderate hip or knee osteoarthritis: early-value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
16 January 2026
Artificial intelligence software to help detect and characterise colorectal polyps
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
5 March 2026
Artificial intelligence-based technologies to aid lung function measurement for the diagnosis of suspected lung conditions: Early Value Assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
2 April 2026
Digital technologies to support smoking cessation in secondary care patients: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
23 April 2026
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
TBC
Magtrace/Sentimag MT599 (MIB263)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
AI in retinal scanning MT524 (MIB265)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
MT656 Paige Prostate AI system for the detection of prostate cancer
Status:
Topic selection
Programme:
Diagnostics guidance
Expected publication date:
TBC
Digital technologies for asthma self-management: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
TBC
Digital technologies that deliver CBT interventions for insomnia and insomnia symptoms (Disordered sleep)
Status:
Awaiting development
Programme:
Health technology evaluation
Expected publication date:
TBC
Pre-operative and post-operative rehabilitation digital tools (and med-tech) for patients undergoing hip or knee surgery
Status:
Awaiting development
Programme:
Health technology evaluation
Expected publication date:
TBC